Search filters

List of works by Mary Ann Anderson

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia

scientific article published on 04 December 2018

BCL2 inhibition in double hit lymphoma.

scientific article

BH3 mimetic therapy: an emerging and promising approach to treating chronic lymphocytic leukemia.

scientific article published in February 2013

Both leukaemic and normal peripheral B lymphoid cells are highly sensitive to the selective pharmacological inhibition of prosurvival Bcl-2 with ABT-199.

scientific article

Charcot-Leyden crystals

scientific article published on 01 November 2010

Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax.

scientific article

Current challenges and novel treatment strategies in double hit lymphomas

scientific article

Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma

scientific article published on 19 November 2018

Persistent complement-dependent anti-AnWj in a lymphoproliferative disorder: a case study and review.

scientific article published on January 2011

Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations

scientific article published on 03 June 2019

Targeting BCL2 for the treatment of lymphoid malignancies

scientific article

The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism.

scientific article published on 11 April 2016

Transformed Lymphoma.

scientific article published on December 2016

Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study

scientific article

Venous thromboembolism management practices and knowledge of guidelines: a survey of Australian haematologists and respiratory physicians

scientific article